NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Saturday, November 21, 2009 7:49 PM

Protherics PLC

Type: Company

Name: Protherics PLC

Fact Sheet: Fact Sheet for Protherics PLC

First Reported 11/06/2009 - Updated 11/06/2009 - 2 Documents (in Corporate Deals)

BTG plc

Drug group acquisition boosts BTG

A full half-year of contributions from Protherics boost revenues at the biotechnology group as it looks forward to the direct marketing of two major drugs in the US next year ... [FT.com - UK Smaller companies - 11/06/2009]

Entities: BTG plc, Acquisition, Protherics PLC

First Reported 11/06/2009 - Updated 11/06/2009 - 1 Documents

Appointments update

PolyTherics has appointed Dr Jeff Edwards (pictured left) and Dr Sally Waterman to its senior management team. Dr Jeff Edwards joins PolyTherics as director of development. Jeff was previously responsible for development at Thiakis, an Imperial College ... [Pharmafocus - 11/06/2009]

Entities: Jeff Edwards, Protherics PLC, BTG

First Reported 11/06/2009 - Updated 11/06/2009 - 1 Documents (in Market News)

Revenues rise at pharmaceuticals company BTG

Drug group acquisition boosts international specialty pharmaceuticals company BTG, Manufacturing Digital has learnt.BTG, the specialty pharmaceuticals company, has announced its interim results for the six months ended September 30, 2009.Pre-tax profits ... [Manufacturing Digital - 11/06/2009]

Entities: BTG, Protherics PLC, Overdose, Gross Profit Margin

First Reported 11/09/2009 - Updated 11/09/2009 - 1 Documents

BTG mulls Varisolve development

A typically complicated set of milestone and royalty payments, boosted by sales of snake anti-venom in the US, helped pharmaceutical specialist BTG turn a small profit at the interim stage, itself a novelty in UK biotech. While the company's main concern ... [Investors Chronicle - 11/09/2009]

Entities: BTG, BTG plc, Multiple Sclerosis, Protherics PLC, varicose vein

First Reported 11/10/2009 - Updated 11/10/2009 - 1 Documents

BTG revenues gain from Protherics buy

UK-based speciality pharmaceutical group BTG saw its purchase of Protherics pay off in a strong set of six-month results that showed swelling sales and gross profit despite a backdrop of difficult economic conditions.In the first full set of six-month ... [Pharma Times - 11/10/2009]

Entities: BTG, Protherics PLC, Toxicity, Gross Profit Margin, Louise Makin

First Reported 10/23/2009 - Updated 10/23/2009 - 1 Documents (in Medicine)

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Women abused by intimate partners suffer higher rates of medical maladiesWomen abused by intimate partners suffer higher rates of a wide variety of doctor-diagnosed medical ...Comprehensive Board Review in Internal Medicine to prepare physicians for ABIM ... [News-Medical.Net - 10/23/2009]

Entities: Bayer HealthCare Pharmaceuticals, Nexavar, Onyx Pharmaceuticals Inc

First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents (in Internet & IT)

UPDATE 1-BTG H1 revenue up 59 pct as sees Protherics boost

* H1 revenues 47.9 mln stg vs 30.2 mln* Pretax profit down following Protherics acquisition(Adds details)LONDON, Nov 5 (Reuters) - British speciality drug company BTG (BGC.L) said on Thursday first-half revenue rose 59 percent as it reaped the benefits ... [Reuters UK - 11/05/2009]

Entities: Protherics PLC, BTG plc, Mark Potter, Acquisition, Biotechnology

First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents (in Biotechnology)

UPDATE: BTG 1st Half Pretax Profit Down 25%; Eyeing Drug Buys

Of DOW JONES NEWSWIRESLONDON -(Dow Jones)- U.K. pharmaceutical company BTG PLC (BGC.LN) Thursday reported a 25% fall in fiscal first-half pretax profit and said it is evaluating a number of specialist medicines it might acquire.BTG is building a U.S. ... [Nasdaq - 11/05/2009]

Entities: BTG plc, Protherics PLC, BTG

First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents (in Internet & IT)

BTG hit by lower sales of snakebite antidote

Pharmaceutical firm BTG is among the biggest fallers in the mid-cap index after its half year results revealed manufacturing problems with its two anti-poison treatments. BTG blamed 'technical issues at a third party supplier' for lower than expected ... [Guardian.co.uk - 11/05/2009]

Entities: BTG, varicose vein, Protherics PLC, Phase III Trial

First Reported 11/06/2009 - Updated 11/06/2009 - 1 Documents (in Market News)

Unilever's quality is hard to beat, buy in

BTG; Millennium & CopthorneEdited by James MooreCloseOur view: BuyShare price: 1794p (-35p)Paul Polman, chief executive of Unilever, has every reason to be cheerful. Since he took over in January – after stints at Nestlé and Proctor & Gamble – efforts ... [The Independent - 11/06/2009]

Entities: Unilever Group, BTG, BTG plc, Millennium & Copthorne Hotels plc

First Reported 05/28/2009 - Updated 05/28/2009 - 1 Documents (in Market News)

Broker snap: BTG to move back into black in 2010

May 2009 BGC - BTG Latest Prices Name Price % BTG 149.25p -0.50% FTSE 250 7,482 -1.40% FTSE 350 2,277 -1.15% FTSE All-Share 2,227 -1.12% 7,349 -0.49% LONDON (SHARECAST) - Broker KBC Peel Hunt has upgraded its profit forecasts for BTG despite the life ... [ShareCast - 05/28/2009]

Entities: BTG, Protherics PLC, KBC Peel Hunt PLC, Acquisition, Mergers & Acquisitions

First Reported 07/15/2009 - Updated 07/15/2009 - 1 Documents

TechMARK movers: Xaar remains cautious

LONDON (SHARECAST) - Xaar dropped after the Cambridge based inkjet printing technology firm said trading for the six months ended 30 June was in line with expectations but behind the first half of last year. "Whilst the board is encouraged by trading ... [ShareCast - 07/15/2009]

Entities: BTG, Protherics PLC, NCC Group

Quotes

...10m reduction in general & administrative expenses and 10m reduction in research & development expenses by the end of the 2010/2011 financial year. "BTG's business is making good progress on all fronts. We are on track to achieve the planned operating and financial synergies from integrating the Protherics business, and we are progressing our plans to establish a US hospital sales force" said CEO Louise Makin. FTSE TechMARK - Risers

TechMARK movers: Xaar remains cautious [ShareCast - 07/15/2009]

BTG also said it was on track to achieve planned cost savings from integration of Protherics. "The operations and portfolio reviews have been completed, and we are on track to achieve the planned annual savings of 10m and reduction in R&D spend of 10m by the 2010/2011 financial year" the group said in a company statement

BTG recurring revenue higher than previous year [ShareCast - 04/02/2009]

More Content

sort by: Date \| Relevance
BTG revenues gain from Protherics buy [Pharma Times - 11/10/2009]
BTG mulls Varisolve development [Investors Chronicle - 11/09/2009]
Revenues rise at pharmaceuticals company BTG [Manufacturing Digital - 11/06/2009]
Appointments update [Pharmafocus - 11/06/2009]
Drug group acquisition boosts BTG [FT.com - UK Smaller companies - 11/06/2009]
Drug group acquisition boosts BTG [FT.com - Health - 11/06/2009]
Unilever's quality is hard to beat, buy in [The Independent - 11/06/2009]
BP biofuel plant ... Emirates profits up ... Ar... [Times Online - 11/06/2009]
TechMARK movers: Profit dip hits BTG share price [Digital Look - 11/05/2009]
BTG hit by lower sales of snakebite antidote [Guardian.co.uk - 11/05/2009]
UPDATE: BTG 1st Half Pretax Profit Down 25%; Ey... [Nasdaq - 11/05/2009]
UPDATE 1-BTG H1 revenue up 59 pct as sees Proth... [Reuters UK - 11/05/2009]
Bayer HealthCare Pharmaceuticals and Onyx Pharm... [News-Medical.Net - 10/23/2009]
Yesterday's trading: Taking a gamble on biotechs [This Is Money - 07/30/2009]
Mortgage lending up ... Dignity profits rise ..... [Times Online - 07/30/2009]
Yesterday's trading: Taking a gamble on biotech... [This Is Money - 07/29/2009]
Ask Andy: BTG has a healthy cash pile [This Is Money - 07/19/2009]
TechMARK movers: Xaar remains cautious [ShareCast - 07/15/2009]
Broker snap: BTG to move back into black in 2010 [ShareCast - 05/28/2009]
Yesterday's trading: Buyers back in the saddle [This Is Money - 04/10/2009]
Hold on to sweetness of Tate & Lyle [The Times - 04/03/2009]
BTG recurring revenue higher than previous year [ShareCast - 04/02/2009]

Change Password

Log in to Silobreaker

Advanced Search Options

Protherics PLC